PMC:4159494 / 26797-27473
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/4159494","sourcedb":"PMC","sourceid":"4159494","source_url":"https://www.ncbi.nlm.nih.gov/pmc/4159494","text":"Clearly, the direct impact of osteosarcopenic obesity is a potential threat to clinical and public health. Considering the effects of low muscle and bone tissues combined with the influence of obesity, it is likely that these individuals will present with poorer clinical outcomes caused by the cascade of metabolic abnormalities associated with these changes in body composition. Regardless of the specific diagnosis cut points for muscle, bone, and adipose tissue that have yet to be determined, there is no doubt that future research is needed to explore the clinical outcomes and appropriate interventions associated with the concurrent appearance of all three conditions.","tracks":[]}